Lilly to seek FDA nod for obesity pill in diabetes after late-stage trial win
- Hims & Hers Health Stock Rallies on Regulatory Pivot. It’s Not About GLP-1s This Time. Barrons —
- Public health plans should cover Mounjaro for type 2 diabetes, Canada’s Drug Agency recommends The Globe and Mail —
- This could be why your weight-loss medication isn’t delivering results Fox News —
- Hims & Hers on track to extend gains as RFK Jr. seeks to loosen peptide regulations Seeking Alpha —